| Cognitive impairment in a population‐based study of patients with multiple sclerosis: differences between late relapsing− remitting, secondary progressive and primary … V Planche, M Gibelin, D Cregut, B Pereira, P Clavelou European journal of neurology 23 (2), 282-289, 2016 | 167 | 2016 |
| High-clearance anti-amyloid immunotherapies in Alzheimer's disease. Part 1: Meta-analysis and review of efficacy and safety data, and medico-economical aspects N Villain, V Planche, R Levy Revue neurologique 178 (10), 1011-1030, 2022 | 73 | 2022 |
| Hippocampal microstructural damage correlates with memory impairment in clinically isolated syndrome suggestive of multiple sclerosis V Planche, A Ruet, P Coupé, D Lamargue-Hamel, M Deloire, B Pereira, ... Multiple Sclerosis Journal 23 (9), 1214-1224, 2017 | 71 | 2017 |
| Structural progression of Alzheimer’s disease over decades: the MRI staging scheme V Planche, JV Manjon, B Mansencal, E Lanuza, T Tourdias, G Catheline, ... Brain Communications 4 (3), fcac109, 2022 | 68 | 2022 |
| Regional hippocampal vulnerability in early multiple sclerosis: Dynamic pathological spreading from dentate gyrus to CA 1 V Planche, I Koubiyr, JE Romero, JV Manjon, P Coupé, M Deloire, ... Human brain mapping 39 (4), 1814-1824, 2018 | 67 | 2018 |
| Posterior lobules of the cerebellum and information processing speed at various stages of multiple sclerosis A Moroso, A Ruet, D Lamargue-Hamel, F Munsch, M Deloire, P Coupé, ... Journal of Neurology, Neurosurgery & Psychiatry 88 (2), 146-151, 2017 | 64 | 2017 |
| Selective dentate gyrus disruption causes memory impairment at the early stage of experimental multiple sclerosis V Planche, A Panatier, B Hiba, EG Ducourneau, G Raffard, N Dubourdieu, ... Brain, behavior, and immunity 60, 240-254, 2017 | 56 | 2017 |
| Deciphering the microstructure of hippocampal subfields with in vivo DTI and NODDI: Applications to experimental multiple sclerosis A Crombe, V Planche, G Raffard, J Bourel, N Dubourdieu, A Panatier, ... Neuroimage 172, 357-368, 2018 | 50 | 2018 |
| US Food and Drug Administration Approval of Aducanumab—Is Amyloid Load a Valid Surrogate End Point for Alzheimer Disease Clinical Trials? V Planche, N Villain JAMA neurology 78 (11), 1307-1308, 2021 | 43 | 2021 |
| Validity and performance of blood biomarkers for Alzheimer disease to predict dementia risk in a large clinic-based cohort V Planche, V Bouteloup, I Pellegrin, JF Mangin, B Dubois, PJ Ousset, ... Neurology 100 (5), e473-e484, 2023 | 42 | 2023 |
| Differential annualized rates of hippocampal subfields atrophy in aging and future Alzheimer's clinical syndrome L Nadal, P Coupé, C Helmer, JV Manjon, H Amieva, F Tison, JF Dartigues, ... Neurobiology of aging 90, 75-83, 2020 | 39 | 2020 |
| Key questions for the evaluation of anti-amyloid immunotherapies for Alzheimer’s disease KY Liu, N Villain, S Ayton, SF Ackley, V Planche, R Howard, ... Brain Communications 5 (3), fcad175, 2023 | 32 | 2023 |
| Complement C3 mediates early hippocampal neurodegeneration and memory impairment in experimental multiple sclerosis J Bourel, V Planche, N Dubourdieu, A Oliveira, A Séré, EG Ducourneau, ... Neurobiology of Disease 160, 105533, 2021 | 30 | 2021 |
| Sturge-Weber syndrome with late onset hemiplegic migraine-like attacks and progressive unilateral cerebral atrophy V Planche, O Chassin, L Leduc, W Regnier, A Kelly, R Colamarino Cephalalgia 34 (1), 73-77, 2014 | 28 | 2014 |
| Pattern separation performance is decreased in patients with early multiple sclerosis V Planche, A Ruet, J Charré‐Morin, M Deloire, B Brochet, T Tourdias Brain and behavior 7 (8), e00739, 2017 | 27 | 2017 |
| White-matter-nulled MPRAGE at 7T reveals thalamic lesions and atrophy of specific thalamic nuclei in multiple sclerosis V Planche, JH Su, S Mournet, M Saranathan, V Dousset, M Han, BK Rutt, ... Multiple Sclerosis Journal 26 (8), 987-992, 2020 | 24 | 2020 |
| Subjective cognitive and non‐cognitive complaints and brain MRI biomarkers in the MEMENTO cohort V Dauphinot, V Bouteloup, JF Mangin, B Vellas, F Pasquier, F Blanc, ... Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 12 (1 …, 2020 | 24 | 2020 |
| Improvement of quality of life and its relationship with neuropsychiatric outcomes in patients with multiple sclerosis starting treatment with natalizumab: a 3-year follow-up … V Planche, X Moisset, R Morello, E Dumont, M Gibelin, J Charré-Morin, ... Journal of the neurological sciences 382, 148-154, 2017 | 24 | 2017 |
| Who performs lumbar puncture, how many do they perform, how and why? A retrospective study of 6,594 cases X Moisset, A Ruet, B Brochet, V Planche, P Jaffeux, V Gilleron, N Ong, ... European neurology 76 (1-2), 8-11, 2016 | 24 | 2016 |
| Intravenous immunoglobulin and rituximab for cerebellar ataxia with glutamic acid decarboxylase autoantibodies V Planche, A Marques, M Ulla, M Ruivard, F Durif The Cerebellum 13, 318-322, 2014 | 23 | 2014 |
